Joshua LaBaer

Joshua LaBaer is an American biochemist and molecular biologist recognized for his pioneering work in functional proteomics and the development of innovative protein array technologies. He has held prominent leadership positions at major research institutions, including directing the Virginia G. Piper Center for Personalized Diagnostics at Arizona State University. His research focuses on the discovery and validation of autoantibodies and protein biomarkers for the early detection of diseases, particularly cancer.

Early life and education

LaBaer completed his undergraduate studies at the University of California, Berkeley, earning a degree in biochemistry. He then pursued his medical doctorate and doctoral degrees through the prestigious Medical Scientist Training Program at the University of California, San Francisco. His graduate and postdoctoral research was conducted in the laboratory of renowned cell cycle biologist David Beach at the Cold Spring Harbor Laboratory, where he investigated mechanisms of cell cycle regulation.

Career and research

LaBaer began his independent career as an assistant professor at Harvard Medical School and a researcher at the Massachusetts General Hospital. He later moved to the Baylor College of Medicine, where he served as a professor and director of the Breast Center. In 2009, he joined Arizona State University as the director of the Biodesign Institute's Virginia G. Piper Center for Personalized Diagnostics. His laboratory is renowned for creating the Nucleic Acid Programmable Protein Array, a high-throughput platform for producing and studying human proteins. This technology is central to his work with the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium and other major initiatives aimed at understanding protein-protein interactions and identifying novel therapeutic targets.

Scientific contributions

LaBaer's most significant contribution is the invention and application of the Nucleic Acid Programmable Protein Array platform, which has revolutionized the field of functional proteomics. His team uses this technology to screen for autoantibodies present in patient serum, which can serve as early indicators for cancers such as breast cancer, ovarian cancer, and pancreatic cancer. He has published extensively in top-tier journals including Nature, Science, and Cell. His research has also advanced the understanding of tumor suppressor proteins like p53 and their roles in DNA damage response pathways, contributing to the broader fields of molecular oncology and personalized medicine.

Awards and honors

LaBaer has been elected a fellow of the American Association for the Advancement of Science in recognition of his contributions to protein array technology and cancer biomarker discovery. His research has been consistently funded by grants from the National Institutes of Health, the Department of Defense, and private foundations such as the Breast Cancer Research Foundation. He has served on review panels for the National Cancer Institute and as an editor for several scientific journals in the fields of proteomics and molecular cancer research.

Personal life

While maintaining a prominent public scientific profile, LaBaer keeps details of his personal life private. He is actively involved in mentoring the next generation of scientists through his roles at Arizona State University and has participated in numerous public science outreach events to discuss the future of cancer diagnostics and biomedical research.

Category:American biochemists Category:American molecular biologists Category:Living people